NCT00130871已完成2 期
Impact of Levosimendan Pretreatment on Weaning From Cardiopulmonary Bypass (CPB) in Patients With Diminished Left Ventricular Function Before Coronary Artery Bypass Grafting (CABG)
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
- 试验地点
- 3
- 主要终点
- Proportion of successful primary weanings
研究概览
简要总结
The study evaluates the efficacy of intravenous levosimendan treatment started during a coronary artery bypass operation to wean patients from a heart lung machine.
详细描述
Levosimendan or placebo infusion is started at the time of induction of anesthesia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Three vessel coronary artery disease.
- •Indication for on-pump coronary artery bypass surgery.
- •Ejection fraction below 50%
排除标准
- •Indication for any cardiac valve surgery
- •Previous coronary artery bypass surgery
结局指标
主要结局
Proportion of successful primary weanings
次要结局
未报告次要终点
研究者
研究点 (3)
Loading locations...
相似试验
已完成
3 期
Preoperative Levosimendan in CABG Patients With Poor LV FunctionCoronary Artery Bypass GraftingLeft Ventricular DysfonctionNCT02184819Assistance Publique - Hôpitaux de Paris335
已完成
4 期
Levosimendan and Myocardial ProtectionMyocardial ProtectionNCT00610350University of Roma La Sapienza100
已完成
不适用
Levosimendan Administration and Outcome in Cardiac SurgeryTreatment of Left Heart Insufficiency in an Operative Setting of Cardiac SurgeryNCT02275013Charite University, Berlin, Germany159
招募中
不适用
Impact of Levosimendan Preconditioning on Critical Care and In-hospital Lengths of Stay After Cardiac Surgery With Bypass SurgeryLevosimendanCardiac SurgeryCardiopulmonary BypassNCT05685537Central Hospital, Nancy, France120
已完成
2 期
Levosimendan for Cardiac Patients Undergoing Major Abdominal Cancer SurgeriesHeart FailureNCT03557255National Cancer Institute, Egypt60